Company Filing History:

13 out of 45

Mect Corporation

patents

Mitsui Toatsu Chemicals, Incorporated

patents

where one patent can have more than one assignee

Years Active: 1988-1998

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5763420 - Method for modulating the immune system (1998-06-09),

2. 5763413 - Lewis-associated compound, process for producing the same, and (1998-06-09),

3. 5668115 - Methods for inhibiting the chemotaxis of neutrophils (1997-09-16),

4. 5516764 - Anti-inflammatory agent (1996-05-14),

5. 5264567 - GM.sub.3 analogous compound (1993-11-23),

6. 5173420 - Monoclonal antibody recognizing un-natural ganglioside GD3 (1992-12-22),

7. 5101026 - Ganglioside related compounds and method of producing the same (1992-03-31),

8. 4990603 - Sialic acid derivatives and process therefor (1991-02-05),

9. 4963653 - Sialic acid-bonded octapeptide and preparation thereof (1990-10-16),

10. 4950750 - Glycolipid containing N-glycolylneuraminic acid and method of producing (1990-08-21),

11. 4918177 - Sialic acid derivatives having active carbonyl group (1990-04-17),

12. 4751290 - Sialosylcerebrosides (1988-06-14),

13. 4730058 - Sialosylceramides and production method thereof (1988-03-08),

Title: Masaaki Numata: Innovator in Immunology

Introduction

Masaaki Numata is a prominent inventor based in Kawagoe, Japan. He has made significant contributions to the field of immunology, holding a total of 13 patents. His work focuses on developing innovative solutions for various medical conditions, particularly those related to the immune system.

Latest Patents

One of Masaaki Numata's latest patents is a method for modulating the immune system. This anti-inflammatory drug comprises at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid, and pharmaceutically acceptable salts thereof. The drug is designed for use in treating renal diseases, hepatitis, and as an immunomodulator. Additionally, it serves as a drug for inhibiting the chemotaxis of neutrophils.

Career Highlights

Throughout his career, Masaaki Numata has worked with notable companies such as Mect Corporation and Rikagaku Kenkyusho. His experience in these organizations has contributed to his expertise in the development of pharmaceutical innovations.

Collaborations

Masaaki Numata has collaborated with several professionals in his field, including Tomoya Ogawa and Mamoru Sugimoto. These partnerships have enhanced his research and development efforts.

Conclusion

Masaaki Numata is a distinguished inventor whose work in immunology has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com